For us, GLP-1s, last year, were number 32, and this year theyre number one [in pharmacy spending]. Human Resources Director, health benefits administrator Before we knew it, we spent half a million dollars and were projected to go up to $1.2 million the following year. Manager of Compensation and Benefits Administration, large retail firm Ill just say our GLP-1 agonist spending year over year was increasing 50% for weight loss
Beyond weight outcomes, the Phase 2 obesity trial also reported improvements in several cardiometabolic markers, including: Reductions in waist circumference Improvements in fasting glucose and insulin sensitivity Favourable changes in blood pressure and lipid profiles Phase 3 trials understood to form part of the TRIUMPH programme are now underway, evaluating retatrutide in broader populations including people with type 2 diabetes and cardiovascular disease
The lipotropic consists of the following: Methionine: helps break down sugars & carbohydrates and convert to energy Inositol: Converts food to energy Choline: Healthy nerve cells, cuts muscle recovery time, helps convert fat to energy Pyridoxine: Promotes red blood cell production plus converts food to energy Cyanocobalamin: Energy, healthy nerve cells Recommend Dose Intramuscular (IM) 1ml/weekly
So now we're basing optimal lab ranges on people who are ill, which is never okay
This leaves a wet cake behind for subsequent process steps
GHK-Cu topical products do not need to be reconstituted